Georgian Approval Process

Georgia has relatively short timelines for study approval procedure.
Clinical study start-up time: 2.5 – 3 months (the shortest approval timeline in Europe).

Georgian Recruitment Potential

Over 230 studies have been registered under the official clinical trial registry in Georgia (41% in cardiovascular diseases, 37 % in oncology, 12% in neurology and 10 % in other therapeutic areas). Patients are generally compliant and willing to participate in clinical trials due to limited access to novel therapies.
In addition to the vast patient population, the naïve patient population is significantly higher than other European nations.

Investigators and Sites

The majority of sites are located in the largest cities with Tbilisi, the capital, hosting the largest and most modern hospitals with expertise in all therapeutic areas. Sites and PIs specialized in cardiovascular diseases are considered the most experienced ones.